Explore
Validate
Learn15764-1-AP
antibody from Proteintech Group
Targeting: MID1IP1
FLJ10386, G12-like, MIG12, STRAIT11499, THRSPL
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15764-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- MID1IP1 antibody
- Antibody type
- Polyclonal
- Description
- MID1IP1 antibody (Cat. #15764-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells.
Euonymus sachalinensis Induces Apoptosis by Inhibiting the Expression of c-Myc in Colon Cancer Cells.
Ophiopogonin D increase apoptosis by activating p53 via ribosomal protein L5 and L11 and inhibiting the expression of c-Myc via CNOT2.
The Antitumor Effect of Timosaponin A3 through c-Myc Inhibition in Colorectal Cancer Cells and Combined Treatment Effect with 5-FU or Doxorubicin.
Inhibition of CNOT2 Induces Apoptosis via MID1IP1 in Colorectal Cancer Cells by Activating p53.
Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.
Park YR, Jee W, Park SM, Kim SW, Jung JH, Kim H, Kim KI, Jang HJ
International journal of molecular sciences 2023 Dec 18;24(24)
International journal of molecular sciences 2023 Dec 18;24(24)
Euonymus sachalinensis Induces Apoptosis by Inhibiting the Expression of c-Myc in Colon Cancer Cells.
Park SM, Jee W, Park YR, Kim H, Na YC, Jung JH, Jang HJ
Molecules (Basel, Switzerland) 2023 Apr 14;28(8)
Molecules (Basel, Switzerland) 2023 Apr 14;28(8)
Ophiopogonin D increase apoptosis by activating p53 via ribosomal protein L5 and L11 and inhibiting the expression of c-Myc via CNOT2.
Ko HM, Jee W, Lee D, Jang HJ, Jung JH
Frontiers in pharmacology 2022;13:974468
Frontiers in pharmacology 2022;13:974468
The Antitumor Effect of Timosaponin A3 through c-Myc Inhibition in Colorectal Cancer Cells and Combined Treatment Effect with 5-FU or Doxorubicin.
Ko HM, Jee W, Park DI, Kim KI, Jung JH, Jang HJ
International journal of molecular sciences 2022 Oct 7;23(19)
International journal of molecular sciences 2022 Oct 7;23(19)
Inhibition of CNOT2 Induces Apoptosis via MID1IP1 in Colorectal Cancer Cells by Activating p53.
Jung JH, Lee D, Ko HM, Jang HJ
Biomolecules 2021 Oct 10;11(10)
Biomolecules 2021 Oct 10;11(10)
Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.
Jung JH, Lee HJ, Kim JH, Sim DY, Im E, Kim S, Chang S, Kim SH
Cells 2020 Apr 16;9(4)
Cells 2020 Apr 16;9(4)
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The MID1IP1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human MID1IP1. This antibody recognizes human,mouse,rat antigen. The MID1IP1 antibody has been validated for the following applications: ELISA, WB analysis.
